Retrospective Evaluation of the Impact of Epidural on the Risk of Postpartum Hemorrhage
NCT ID: NCT06816654
Last Updated: 2025-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5753 participants
OBSERVATIONAL
2023-12-12
2024-05-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators retrospectively analyzed 5753 records of patients who gave birth vaginally at Brugmann University Hospital between January 1, 2020 and December 31, 2021. The primary objective was to assess whether epidurals pose a risk of postpartum hemorrhage. Secondly, the investigators assessed whether epidurals pose a greater risk of instrumentation of delivery and emergence of PPH risk factors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Epidural on Trauma of the Genital Tract During Peripartum
NCT07255014
Postpartum Hemorrhage: Incidence and Risk Factors
NCT05525143
Chronic Pain After Childbirth - Caesarean Section Compared to Vaginal Delivery and the Impact of Pre-existing Pain
NCT03216044
Outcomes After the Implementation of a New Oxytocin Protocol
NCT02722356
Post-dural Puncture Headache: A Retrospective Study
NCT03790124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaginal deliveries
Patients who gave birth vaginally at Brugmann University Hospital between January 1, 2020 and December 31, 2021.
Data extraction from medical records
Data extraction from medical records
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data extraction from medical records
Data extraction from medical records
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who gave birth outside of hospital.
* Patients who had recourse to a medical termination of pregnancy (MTP).
* Patients who gave birth by cesarean section.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tatiana Besse-Hammer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tatiana Besse-Hammer
Head of Clinical Trial Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Botti, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Brugmann
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Brugmann
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUB-PERIHPeriPartum
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.